Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Tuesday, February 9, 2010, 11:17pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares,
Sign-in
or
Register
Finance Home
Investing
Volume Leaders
Local Markets
US Markets
International Markets
Advances & Declines
ETFs
Income Trust News
News & Opinion
Markets
Industry
RSS-My Yahoo!
Personal Finance
Banking & Budgeting
Calculators
Insurance
Retirement
Taxes
My Portfolios
Sign In to Create/Edit My Portfolios
Get Quotes
Symbol Lookup
Exchanges
VIVUS Inc. (VVUS)
At 16:00 EST:
8.46 USD
0.22 (2.67%)
MORE ON VVUS
Quotes
Summary
Options
Historical Prices
Charts
Interactive
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheets
Cash Flow
VIVUS, Inc.
(NGM:VVUS) Delayed quote data
After Hours:
8.45
0.01 (0.12%)
as of 7:59pm EST on 02/09/10
Last Trade:
8.46 USD
Trade Time:
4:00PM EST
Change:
0.22 (2.67%)
Prev Close:
8.24
Open:
8.30
Bid:
N/A
Ask:
9.94
x 300
1y Target Est:
12.33
Day's Range:
8.17 - 8.50
52wk Range:
2.72 - 12.88
Volume:
2,353,191
Avg Vol
(3m)
:
3,469,400
Market Cap:
681.44M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-0.68
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Add VVUS to Portfolio
Download Data
HEADLINES
Lightning Round OT: Patriot Coal, Boeing and More
at CNBC
(Thu, Feb 4)
Ahead of the Bell: Arena Pharma upgraded
AP
(Thu, Feb 4)
VIVUS to Present at the BIO CEO and Investor Conference
PRNewswire
(Thu, Feb 4)
Orexigen shares rise on Jefferies analyst view
AP
(Tue, Feb 2)
Lightning Round OT: China Automotive Systems, Vivus and More
at CNBC
(Fri, Jan 29)
[$$] Five Drugs That Could Be Blockbusters
at Barrons.com
(Fri, Jan 29)
Sector Snap: FDA nod boosts diabetes drugmakers
AP
(Tue, Jan 26)
Investors betting heavily on Vivus obesity drug
at MarketWatch
(Thu, Jan 21)
The Skinny On Vivus
at CNBC
(Wed, Jan 20)
Drug News: Impotence, Arthritis and Schizophrenia
at The Wall Street Journal Online
(Mon, Jan 11)
Biotech Stocks: MAP, Inhibitex, Vivus lead drug stocks north
at MarketWatch
(Mon, Jan 11)
More Headlines for VVUS...
ANALYST
EPS Est (next year)
(Dec-09)
:
-0.83
EPS Est (in 2 years)
(Dec-10)
:
-0.71
Avg Rec (current)*:
2.3
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
VIVUS, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products for underserved markets in the United States.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Symbol Lookup
Latest News
Canadian Indices